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1. 1. The aim of the research
Determination of the effect of activation and blockade of CCS on the course of traumatic 
brain injury.
1. 2. Problem description
Today in the world one of the leading causes of death and disability among the work-
ing-age population of the earth is traumatic brain injury (TBI). Especially the situation has 
changed in the last 10–15 years [1, 2], the number of man-made disasters, natural disasters, 
acts of terrorism and military conflicts on earth has sharply increased, which is accompanied 
by a high degree of trauma, in the structure of which the damage to the skull and brain is more 
than 1/3 of all injuries [2–4]. In different countries, traumatism in the structure of mortality 
follows cardiovascular and oncological diseases, but the economic and medico-social damage 
caused to society brings TBI to the first place. Every year, both the TBI itself and its long-term 
A B S T R A C T
The aim of the research. To study effects of activation and inhibition of the central cholin-
ergic systems (CCS) in traumatic brain injury (TBI).
Studied problem. To investigate the influence of the reactivity of the central cholinergic 
systems on the course of the acute period of traumatic brain injury, in an acute experiment 
on laboratory animals in vivo.
The main scientific results. It was found that in the acute period of TBI (the first three 
days), both activation and blockade of CCS led to a decrease in mortality, which was sta-
tistically confirmed only for their activation. The control group was characterized by the 
progression of neurological deficit, which was realized due to motor disorders and reflex 
sphere. Upon activation of the CCS, the degree of neurological deficit was significantly 
less than in other groups, but, nevertheless, it increased from 48 hours after the injury, as 
regards behavioral and consciousness disorders. Inhibition of cholinergic systems led to 
a sharp increase in neurological deficit in all areas immediately after injury, to a greater 
extent due to reflex disorders. This, together with a high mortality rate, indicated a negative 
effect of the pharmacological shutdown of CCS in TBI.
The area of practical use of the research results. The obtained results will allow a deeper 
study of the influence of the central cholinergic systems on the course and descent of TBI. 
To develop effective methods of pharmacological correction in the treatment of patients in 
the acute period of TBI.
Innovative technological product: pathogenetically substantiated medical treatment of 
the acute period of traumatic brain injury, development of new methods of pharmacolog-
ical neuroprotection for persons with a priori high risk of injury, development of effective 
options for reducing mortality and disability from TBI.
Scope of the innovative technological product. The important role of CCS in the re-
alization of the response of the central nervous system to TBI was established, and the 
possibility of using pharmacological stimulation of the central nervous system with choli-
nomimetics of the central type of action was justified.
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consequences cost the world economy about 400 billion US dollars, which is about 0.5 % of 
the total gross world product [5].
In Ukraine, this indicator is 2–3 times higher than in economically developed countries. 
These indicators have increased significantly since the end of 2014, which is directly related to the 
situation in the country, aggravated by the conflict and hostilities in the east of Ukraine. According 
to the data published by the OSCE monitoring mission [6], traumatization as a consequence of ex-
plosive impacts and injuries has sharply increased, while this indicator is high both among military 
personnel and among the civilian population.
The sequence of events that occur after brain injury consists of necrosis, axonal damage, 
gliosis/microgliosis, apoptosis, demyelination and neuroregeneration [7]. The first acute period is 
of the greatest importance for the formation of an adequate response [8]. It is at this time that the 
main causal relationships are established, which determine the further development of the disease, 
its severity and outcomes, which gives reason to focus not only on the clinical, but also on the 
pathogenetic significance of this period [9].
In traumatic brain injury in the population of neurons there is a complex of interdependent 
extra- and intracellular processes triggered by tissue ischemia [10]. The latter serves as a trigger 
mechanism for events that ultimately lead to degeneration and death of neurons. The immediate 
cause of the primary phase is mechanical damage, which is irreversible, including cell destruction 
and vascular damage; manifested by brain contusion, intracranial hemorrhage, diffuse axonal dam-
age [7]. A key role at this stage belongs to calpain (a family of cytosolic neutral Ca2+ – activated 
cysteine proteases), which triggers neurodegeneration and apoptosis [11]. The secondary phase 
includes cascades of neurochemical and neurometabolic events, apoptosis of neurons in isolated 
areas of the brain; mediated by caspases and manifested by intracranial hypertension, edema and 
hypoxia of the brain [11, 12].
One of the main mediators of the CNS is acetylcholine, which mediates its action through 
muscarinic (M–) and nicotinic (N–) receptors, which are widely expressed in the brain [13, 14]. 
The former are associated with G-proteins and mobilize intracellular calcium or reduce the content 
of cyclic adenosine monophosphate. The second are Na+–, K+– and, sometimes, Ca2+ ion channels. 
The latter are of great importance in the implementation of neuroplasticity, cognitive processes, 
neuroprotection [15, 16]. From the very beginning of the damaging effect of trauma, the activity 
of central cholinergic systems (CCS) and the release of acetylcholine decreases, the expression of 
cholinergic receptors decreases and acetylcholinesterase is activated [17, 18].
1. 3. Suggested solution to the problem
The introduction of the cholinomimetic cytidine-5’-choline diphosphate in TBI improves 
the cognitive abilities in the experiment and the release of acetylcholine [19]. The neuroprotec-
tive effect of the drug is associated with the induction of activation of nicotinic α7 receptors [20]. 
On the other hand, studies using the acetylcholinesterase blocker donepezil have had mixed 
results. Thus, it has been shown that it enhances neurogenesis and improves cognitive function 
after TBI [21], which has not been confirmed in other works [22].
The aim of the study was to analyze the effect of changes in central cholinoreactivity on 
mortality and neurological deficit in the acute period of experimental traumatic brain injury.
2. Material and methods
The study was performed on white male Wistar rats weighing 200–215 g, aged six months 
(n=101). The conditions of the Declaration of Helsinki (General Assembly of the World Medical As-
sociation, 2008), norms and principles of the European Convention for the Protection of Vertebrate 
Animals used for research and other scientific purposes were strictly observed.
2. 1. Experimental procedures
Cholinergic and cholinolytic effects on the CNS were simulated by the introduction of central 
cholinomimetics and cholinoblockers. For this we used certified pharmaceuticals: choline alfoscerate 
(“Gliatilin”, “Pharmacor PRODUCTION”, RF; central cholinomimetic, which enhances the transmis-
sion of impulses in cholinergic neurons, improves cell neuroplasticity, receptor function and synaptic 
acid transmission) and (“Akineton”, “Laboratorio PHARMACEUTICO SIT, srl”, Italy; anticholiner-
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gic drug of central action, which reduces the activity of cholinergic neurons in the CNS). To achieve 
an effective concentration of substances in the brain structures and maximum cholinomodulatory 
effect on the CNS, as well as taking into account the periods of accumulation of active substance and 
half-life, clearance of excretion, allowable daily dose and based on the average weight of the animal, 
such a scheme was administered. For 24, 12, 6 and 1 hour before modelling TBI we intraperitoneally 
administered: in the 1st group Ringer’s solution 0.5 ml (control); in the 2nd group – Ringer’s solution 
0.47 ml and 0.03 ml of choline alfoscerate (the dose was 6 mg/kg); and in the 3rd group – Ringer’s 
solution 0.44 ml and 0.06 ml of biperiden hydrochloride (the dose was 0.6 mg/kg).
TBI was applied by the standard method when the metal load fell freely on the fixed head of 
the animal [23]. The load was a round metal rod weighing 50 g, which moved freely along a metal 
tube 65 cm long, fixed strictly perpendicular to the metal frame. Using superficial ether anesthesia, 
the animal’s head was fixed under a vertically arranged metal tube so that the opening of the tube 
was along the sagittal suture and symmetrically 5 mm forward of the intraarticular line. The load 
fell freely along the tube and struck a single blow on the skull. According to our preliminary data, 
this model made it possible to obtain a clearly standardized moderate TBI [23]. Pathological ex-
amination showed that the animals were simulated closed traumatic brain injury in the presence of 
subcutaneous hematoma, without displacement of the brain and with crushing of the temporal and 
parietal cortex in the area of impact – the base of the frontal and temporal lobes. Numerous diffuse 
small hemorrhages were observed in the substance of the brain.
To assess the severity of TBI, a 100-point scale for determining neurological deficit was 
chosen [23], which was used for a separate assessment (in points) of the level of consciousness – 
0–20 points; state of the reflex sphere, which included the width and reaction of the pupils to 
light, corneal reflex, hearing, muscle tone of the torso and extremities – 0–28 points; breathing – 
0–12 points; movement and locomotor functions – 0–25 points, as well as some behavioural reac-
tions with the ability to perform elementary functions – 0–15 points.
The obtained results were subjected to statistical processing using a package of licensed pro-
grams for applied statistics SPSS 11.0, MedStat, MedCalc (MedCalc SoftWare bvba, 1993–2013). 
Conducted a comparative and correlation analysis of data from intact, control and experimental 
groups. The following methods of parametric statistics are used in the work: conducted an analysis 
of normality (criteria χ-square and Kolmogorov-Smirnov). The following statistical indicators were 
calculated: mean value, statistically significant differences, mean and standard deviations, standard 
error. In order to assess the calculations of the average sample population used a parametric criterion 
of difference – t-Student, which is used to assess the dependent and independent data.
3. Results
In animals during the first three days after TBI mortality in the groups differed significant-
ly, that is shown in Table 1. No mortality was determined when CCS (1st group) was activated, 
whereas CCS blockade was accompanied by a mortality of 12.5 %, which was twice less than in the 
control (25.0 %). The difference in mortality between the control and the group with CCS blockade 
was not statistically significant (p=0.204).
Table 1





1st (control) 8 25.0
0.0102nd (CCS – activation) 0 0.0
3rd (CCS – blockade) 4 12.5
Note: p – statistical significance (accepted at P<0,05) by Pearson’s χ2 criterion with Yates correction; paired intergroup compari-
sons: 1st vs 2nd – p=0.003; 1st vs 3rd: p=0.204; 2nd vs 3rd – p=0.040
Thus, both activation and blockade of central cholinergic systems led to a decrease in mor-
tality, which was statistically confirmed only for their activation (p=0.003).
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The degree of neurological deficit in the group of intact animals remained unchanged 
throughout the experiment and amounted to 5.4±0.76 points, which reflected, in our opinion, in the 
physiological characteristics of rodents. Thus, in some animals there were minor violations of the 
reflex sphere (from 4 to 8 points), which were reflected in the weakening of the pupillary response 
to light and the corneal reflex, spastic tone of the torso muscles and decreased pain response. This 
indicator was considered by us as a starting point in the following comparisons in the dynamics of 
the acute period of TBI.
3 hours after TBI, the neurological deficit in the 1st (control) group was 25.6±4.21 points, 
which is 4.7 times higher than baseline in Table 2. In general, in animals of this group, the 
changes were associated with a change (darkening/stupor) in the level of consciousness, im-
paired behavioural responses and decreased reflexes. In half of the animals, the tone of the body 
and limbs became spastic, atactic manifestations appeared during movements. Probably due to 
compensatory or stress-related mechanisms, the frequency of respiratory movements also in-
creases. In the 2nd group (activation of CCS) no significant changes in neurological status were 
observed. The degree of neurological deficit varied insignificantly, and was 25 % higher than 
baseline (p>0.05). Changes were observed exclusively in the reflex sphere: there was a decrease 
in response to sound stimuli and pain sensitivity. The maximum increase in neurological deficit 
was observed in group 3 (CCS suppression), the total score was 7.7 times higher than base- 
line (p<0.05). The level of consciousness in these animals was characterized as “darkening/stu-
por”, was determined by a moderate or severe deficiency of the reflex sphere: reduction/absence 
of perception of light, sound and pain stimuli. There was a marked decrease in muscle tone of 
the body and limbs, the animals were lethargic, adynamic, did not respond to the actions of the 
experimenter. All rats in the group had bradypnea.
Table 2
Neurological deficit in the experimental groups (in points; M±m)
Group
Time after injury, hours
3 24 48 72
1st (control) 25.6±4.2 32.8±2.5 42.3±2.2 51.3±3.0
2nd (CCS – activation) 6.8±0.6* 7.3±0.5* 12.5±1.3* 16.8±1.7*
3rd (CCS – blockade) 41.4±1.9* 46.1±1.3* 51.3±1.2* 52.9±1.1
Note: * – p<0.05 in comparison with the 1st group (control)
After 24 hours, the average score in the animals of the 1st group was 32.8±2.47, mainly 
due to the increase in the deficit in the reflex and motor spheres. The indicators in the 2nd group 
remained practically unchanged, where in all animals the decrease in the reaction to the light stim-
ulus was determined. Neurological deficit increased 9.5 times (p<0.05) in the 3rd group, where all 
animals had no indicators of the reflex sphere, while maintaining a high spastic tone of the extrem-
ities. Other indicators remained at the level corresponding to 3 hours after TBI.
48 hours after the injury in the 1st group, the neurological deficit was almost 8 times higher 
than the initial values and amounted to 42.3±2.21 points. At the same time, in 1/3 of animals the 
neurological deficit continued to grow. In the 2nd group by this time there was an increase in the 
degree of neurological deficit (2.3 times compared to the initial), which was statistically significant 
(p<0.005). This was due to the appearance of motor disorders in 1/3 of the animals. In group 3, the 
total score continued to increase, and was 9.5 times higher than the original (p<0.05). In addition 
to the previously described disorders, in 2/3 of the animals there was dilation of the pupils, exoph-
thalmos, complete lack of response to light stimuli.
72 hours after injury in animals of group 1, the degree of neurological deficit increased 
9.5 times compared to baseline (p<0.05) and amounted to 51.3±2.98 points. Conventionally, 
the animals were divided into two almost equal levels of subgroups: “moderate disorders” – 
a steady decrease in neurological parameters, and “severe disorders” – their complete and 
persistent absence. In the 2nd group there was a significant positive dynamics against the 
35
Innovative technologies in healthcare
background of increasing neurological changes: half of the animals had a persistent distur-
bance of consciousness, however, they adhered to purity, actively responded to the actions of 
the experimenter. In group 3, the degree of neurological deficit continued to increase (almost 
10 times compared to baseline and amounted to 52.9±1.13 points. All indicators of the reflex 
sphere were evaluated by the maximum score, the animals were in a state of stupor. Animals 
3rd and, in part, the 1st group (with “pronounced disorders”) stopped taking care of them-
selves, they remained brady and had apparently increased hypoxia, as evidenced by cyanosis 
of the extremities, there was a refusal of animals from food and water, body weight decreased 
by 15–25 g in comparison with the initial one.
In general, a comparison of the dynamics of the degree of neurological deficit in groups of 
animals showed a tendency to increase it in the acute period of TBI in Fig. 1. The greatest progres-
sion was characteristic of the 1st group, where the degree of neurological deficit doubled during the 
observation period (p<0.05). This reflected the progression of pathological changes in the brain in 
the acute period of TBI.
Fig. 1. Dynamics of the degree of neurological deficit in the acute period of TBI in groups of 
animals (points): * – p<0.05 in comparison with initial indicators
In group 2, the degree of neurological deficit was significantly lower than in other groups, 
but still statistically significantly increased from 48 hours after injury. Apparently, the initial acti-
vation of the central cholinergic systems prevented neurological disorders immediately after TBI. 
However, in the future the neurological deficit had a positive trend.
In the 3rd group, the indicators of the degree of neurological deficit also progressed – 
1.3 times (P<0.05) after 48 hours, compared with the level of 3 hours. This indicated that the initial 
inhibition of cholinergic systems immediately after injury led to a sharp increase in neurological 
deficit. This, together with high mortality, indicated a negative effect of pharmacological exclusion 
of brain cholinergic systems in TBI.
A detailed analysis of the dynamics of the degree of neurological deficit by areas showed 
some differences in the selected groups (Tables 3–5). In the 1st group in all areas there was a sta-
tistically significant increase in the score of neurological deficit in Table 3. The biggest changes 
concerned motor disorders and the reflex sphere. This indicated that in the basic model of TBI, 
coordination of movements and higher nervous activity were more damaged.
In group 2, against the background of activation of cholinergic systems of the brain, the total 
score, as already mentioned, was the lowest. However, from 24 hours after the injury there was an 
increase. It was found that these disorders were more related to disorders of behaviour, conscious-
ness and reflexes in Table 4.
Although motor disorders appeared after 48 hours, they were minimal and mainly related to 
impaired coordination. Thus, it could be concluded that the previous activation of central choliner-
gic systems significantly reduced disorders in all neurological areas, especially – motor disorders.
In group 3, against the background of blockade of the central cholinergic systems, 3 hours 
after TBI, the total score was maximum in groups in all neurological areas. The maximum changes 
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Table 3
Indicators of neurological deficit (in points; M±m) in the 1st group (control)
Indicator
Time after injury, hours
p
3 24 48 72
Conscious. 5.42±0.42& 5.00±0.87& 5.83±0.83& 7.50±0.75*#$ 0.027
Reflexes 10.08±1.20#$& 13.42±0.97*$& 18.33±1.15*# 21.58±1.60*# <0.001
Breath 3.00±0.90#$& 6.00±0.00* 6.00±0.00* 6.00±0.00* <0.001
Movements 2.92±0.97$& 3.75±0.65& 5.42±0.42*& 7.92±0.74*#$ <0.001
Behaviour 4.17±1.11$& 4.58±0.97$& 6.75±0.87*# 8.50±0.45*# <0.001
Note: * – the difference from the indicator at the time of 3 hours is statistically significant, p<0.05; # – the difference from the 
indicator at the time of 24 hours is statistically significant, p<0.05; $ – the difference from the indicator at the time of 48 hours is 
statistically significant, p<0.05; & – the difference from the indicator at the time of 72 hours is statistically significant, p<0.05
Table 4
Indicators of neurological deficit (in points; M±m) in the 2nd group (activation of CCS)
Indicator
Time after injury, hours
p
3 24 48 72
Conscious. 0.00±0.00& 0.00±0.00& 0.94±0.50& 2.50±0.65*#$ <0.001
Reflexes 6.75±0.54& 7.50±0.44& 7.88±0.35& 9.19±0.56*#$ 0.005
Breath 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 >0.999
Movements 0.00±0.0$& 0.00±0.00$& 1.88±0.63*# 1.88±0.63*# <0.001
Behavior 0.00±0.00$& 0.00±0.00$& 1.81±0.68*#& 3.19±0.69*#$ <0.001
Note: * – the difference from the indicator at the time of 3 hours is statistically significant, p<0.05; # – the difference from the 
indicator at the time of 24 hours is statistically significant, p<0.05; $ – the difference from the indicator at the time of 48 hours is 
statistically significant, p<0.05; & – the difference from the indicator at the time of 72 hours is statistically significant, p<0.05
Table 5
Indicators of neurological deficit (in points; M±m) in the 3rd group (blockade of CCS)
Indicator
Time after injury, hours
p
3 24 48 72
Conscious. 6.07±0.57& 6.43±0.63& 7.14±0.69 7.86±0.69*# 0.010
Reflexes 18.79±1.19$& 22.00±0.58$& 25.93±0.60*# 26.50±0.36*# <0.001
Breath 6.00±0.00 6.00±0.00 6.00±0.00 6.00±0.00 >0.999
Movements 5.00±0.00 5.00±0.00 5.00±0.00 5.36±0.36 0.403
Behaviour 5.93±0.57$& 6.64±0.36 7.21±0.21* 7.21±0.21* 0.018
Note: * – the difference from the indicator at the time of 3 hours is statistically significant, p<0.05; # – the difference from the 
indicator at the time of 24 hours is statistically significant, p<0.05; $ – the difference from the indicator at the time of 48 hours is 
statistically significant, p<0.05; & – the difference from the indicator at the time of 72 hours is statistically significant, p<0.05
The average score of reflex disorders in the 3rd group in all terms significantly exceeded 
that in the 1st and 2nd groups in Fig. 2. This result showed that the blockade of the central cholin-
ergic systems worsens primarily the reflex sphere, and, consequently, the subtle mechanisms of 
conjugation of the various departments of the CNS. This fact indicates the importance of activating 
the cholinergic systems of the brain in TBI for the implementation of complex reflex processes of 
nervous regulation.
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Fig. 2. Dynamics of reflex sphere disorders by groups (in points). The vertical axis is the score of 
neurological deficit. See statistical differences in Tables 3-4
4. Discussion
Regarding the comparison of motor disorders, it can be noted that the activation of cholinergic 
systems of the brain generally blocks such disorders, while in other groups they have a significant 
degree of severity. At the same time, if in the control group such violations systematically increase, 
then at blockade immediately after an injury reach rather high degree and then remain stable.
In the plan of negotiation of certain results, it is necessary to mean that the central holino-
receptors are in the foldable large-capacity bottles, as all the structural elements for the adaptation 
of the chemical signal, trigger the local alleviation of the concentration of acetylcholine allosteric 
machines [24]. Holinoreceptors are a superfamily of pentameric ligand-controlled channels, in-
cluding receptor 5-hydroxytryptamin, able to inhibit anion-selective γ-aminobutyric acid type A 
(GABA-AR), glutamate [23]. At the same time, the activity of cholinoceptors is allosterically mod-
ulated by membrane lipids, fatty acids, steroids, instead of those in the brain tissue in TBI, it grows 
rapidly [8, 9, 25, 26].
Also, of the folding structure of holinoreceptors and of the modular flowing into the neuro-
chemical systems is a factor of the primary post-traumatic disorder, which can be explained by the 
fact that there is a reason for the diagnosis.
As one of the main reasons of TBI, there is a particular significance of a wider spread of 
cholinoreceptors in the central nervous system, which is indicated for the hipocampus, tonsils, 
hypothalamus, frontal measles and mediodorsal nucleus of the thalamus [27]. The state-of-the-art 
and chronic systemic introduction of nicotine and other analogues in the structure significantly 
increased the work memory in the labyrinth and slowed down amnestic effects of the antagonist of 
NMDA-glutamate receptors in the dygozocylpirin [27]. Thus, we have seen a decrease in mortality 
and neurological deficiency in patients with TBI on the basis of post-mortem administration of an 
alfoscerate to explain the important role of CHS in the implementation of adaptive reactions, to 
bring the pathogenic importance of this need for malnutrition.
The impairment of the central nervous system function, which is an inherited TBI, includes 
cholinergic mechanisms [28]. It has been shown that in the case of contusion traumas of measles 
to the brain, the capacity of cholinergic and glutamate NMDA receptors decreased, as well as 
the expression of calcium channels, especially in the case of alpha7-cholinoceptor type. The very 
temporomandibular penetration is associated with neurodegeneration and significant neurological 
deficiency due to TBI [28]. Deficiency of the expression of alpha7-cholinoreceptor in cognitive 
impairment in TBI, while nicotinic receptor agonists restore this deficiency and lead to significant 
cognitive improvement compared with the control group. Use of the allosteric modulator of al-
pha7-cholinoreceptors AVL-3288 increased cognitive functions, while working memory in the wa-
ter labyrinth was getting worse, which preceded the atrophy of the hipocampus due to percussion 
of TBI. It allowed to stand up, to strengthen the cholinergic transmission for the development of 
positive allosteric modulation of alpha7-cholinoreceptors, which can be a new therapeutic method 
for reducing the damage to the nervous system in patients with TBI.
In addition, the specific activation of alpha7-cholinoreceptors reduces the penetration of the 
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cholinesterase galanthamine, which, in addition, is allosterically susceptible to signal transmission 
in N-cholinoreceptors and changes in the degeneration of GABA-ergic neurons in hypochondriacal 
cells. In our opinion, the positive effect of cholin alfoscerate can be explained by the very modula-
tory infusion of alpha7-cholinoreceptors, which outstrips the calcification mechanisms of the nerve 
tissue, as in TBI, which in primary trauma are primary and irreversible due to calpain activation, 
leading to apoptosis and neurodegeneration. 
Thus, the study showed a significant effect of activation/inhibition of central cholinergic 
systems on the acute period of TBI. The positive results obtained using the central cholinomimetic 
choline alfoscerate, allow us to continue research to study the mechanisms of the effect.
Study limitations. Given the increase in the neurological deficit in the dynamics of obser-
vation during the activation of CCS, it is advisable to continue research on the use of drugs after 
the application of TBI.
Prospects for further research. The obtained results showed the prospects of using central 
cholinomimetics for the correction of neurological disorders in the acute period of trauma. It is 
necessary to find out the mechanisms of such influence in the future.
5. Conclusions
1. In the acute period of TBI, both activation and blockade of CCS leads to a decrease in 
mortality, which was statistically confirmed only for their activation.
2. Comparison of the degree of neurological deficit showed a clear tendency to increase 
against the background of TBI. The greatest progression was characteristic of the control group, 
where the degree of neurological deficit doubled during the observation, which was realized due to 
motor disorders and reflex sphere.
3. With the activation of central cholinergic systems, the degree of neurological deficit was 
significantly lower than in other groups, but still increased from 48 hours after injury, related to 
behavioural and conscious disorders.
4. Inhibition of cholinergic systems immediately after injury led to a sharp increase in neu-
rological deficits in all areas, but, more, due to reflex disorders. This, together with high mortality, 
indicated a negative effect of pharmacological exclusion of cholinergic systems of the brain on the 
background of TBI.
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